Benefit Restrictions and Gout Treatment

BACKGROUND: Gout is a chronic rheumatic disease that can have serious sequelae, including persistent pain, nerve compression, joint destruction and deformities if left untreated. Febuxostat, initially introduced in the United States in 2009, was the first new treatment option for gout in over 40 yea...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Sharon M., Aranda, Jr., Gustavus A., Gao, Sara, Patel, Bimal V.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Academy of Managed Care Pharmacy 2013
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10437440/
https://www.ncbi.nlm.nih.gov/pubmed/24156646
http://dx.doi.org/10.18553/jmcp.2013.19.9.773

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10437440/
https://www.ncbi.nlm.nih.gov/pubmed/24156646
http://dx.doi.org/10.18553/jmcp.2013.19.9.773

Ejemplares similares